侯富军

2007-2017, 西北农林科技大学，学士，博士

2015-2016，哈佛大学医学院，博士（联合培养）

2017-2021，浙江大学医学院，博士后，助理研究员

2021-2024，Virogin Biotech, 临床前研发总监

2024-至今，华东师范大学，专任副研究员

侯富军，擅长病毒学研究及疫苗开发，以第一作者（含共一）在Nature Microbiology, Nature Communications等发表多篇论文。

代表性论文 (^#: co-first author)

1，Hou F^#, Zhang Y^#, Liu X^#, Murad YM, Xu J, Yu Z, Hua X, Song Y, Ding J, Huang H, Zhao R, Jia W, Yang X. mRNA vaccines encoding fusion proteins of monkeypox virus antigens protect mice from vaccinia virus challenge. Nat Commun. 2023 Sep 22;14(1):5925. 

2，Sun B^#, Yang X^#, Hou F^#, Yu X, Wang Q, Oh HS, Raja P, Pesola JM, Vanni EAH, McCarron S, Morris-Love J, Ng AHM, Church GM, Knipe DM, Coen DM, Pan D. Regulation of host and virus genes by neuronal miR-138 favours herpes simplex virus 1 latency. Nat Microbiol. 2021 May;6(5):682-696.

3，Hou F^#, Sun Z^#, Deng Y^#, Chen S, Yang X, Ji F, Zhou M, Ren K, Pan D. Interactome and Ubiquitinome Analyses Identify Functional Targets of Herpes Simplex Virus 1 Infected Cell Protein 0. Front Microbiol. 2022 Apr 18;13:856471.

4，Xu H^#, Wang J^#, Deng Y^#, Hou F, Fu Y, Chen S, Zou W, Pan D, Chen B. Two-Color CRISPR Imaging Reveals Dynamics of Herpes Simplex Virus 1 Replication Compartments and Virus-Host Interactions. J Virol. 2022 Dec 21;96(24):e0092022.

5，Wang S, Hou F, Yao YF, Pan D. Efficient establishment of reactivatable latency by an acyclovir-resistant herpes simplex virus 1 thymidine kinase substitution mutant with reduced neuronal replication. Virology. 2021 Apr;556:140-148.

6，Lu C, Zhang Y, Liu X, Hou F, Cai R, Yu Z, Liu F, Yang G, Ding J, Xu J, Hua X, Cheng X, Pan X, Liu L, Lin K, Wang Z, Li X, Lu J, Zhang Q, Li Y, Hu C, Fan H, Liu X, Wang H, Jia R, Xu F, Wang X, Huang H, Zhao R, Li J, Cheng H, Jia W, Yang X. Heterologous boost with mRNA vaccines against SARS-CoV-2 Delta/Omicron variants following an inactivated whole-virus vaccine. Antiviral Res. 2023 Apr;212:105556.

7，Li X, Wang H, Lai W, Liao J, Mo W, Huang K, He L, Liang X, Yu Z, Xu J, Hua X, Hou F, Ding J, Jia WW, Zhang K, Wang Y. Prevention and treatment of HPV-related cancer through a mRNA vaccine expressing APC-targeting antigen. Immunology. 2024 Jul;172(3):375-391.

专利

1，专利名称：编码新型冠状病毒S蛋白的mRNA疫苗

公开号：CN116768988A

发明人：威廉·贾; 刘晓虎; 陆昌瑞; 杨晓明; 张云涛; 侯富军; 杨国环; 程新华; 余志斌; 丁隽; 林康; 徐江; 华先武; 潘欣萍; 刘连晓

2， 专利名称：编码新型冠状病毒S蛋白的mRNA疫苗

    公开号：CN116768987A

发明人：威廉·贾; 刘晓虎; 陆昌瑞; 杨晓明; 张云涛; 侯富军; 杨国环; 程新华; 余志斌; 丁隽; 林康; 徐江; 华先武; 潘欣萍; 刘连晓

3， 专利名称：针对痘病毒的信使核糖核酸疫苗

公开号：CN116712536A

发明人：刘小虎; 亚纳尔·穆拉德; 侯富军; 贾为国; 余志斌; 丁隽

4，专利名称：用于检测食蟹猴多瘤病毒的核酸分子、试剂盒和方法

公开号：CN116121449A

发明人：钟宇; 侯富军